Sands Capital Ventures, LLC Dice Therapeutics, Inc. Transaction History

Sands Capital Ventures, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	SELL	$19.77 - $42.23 $7.91 Million - $16.9 Million	-400,000 Reduced 12.7%	2,748,970 $85.8 Million
Q3 2021 Nov 04, 2021	BUY	$31.92 - $37.0 $101 Million - $117 Million	3,148,970 New	3,148,970 $103 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Sands Capital Ventures, LLC, based on Form 13F filings with the SEC.

Stay updated on Sands Capital Ventures, LLC with notifications on news.